Isolation of nucleic acids using the column method
#benefitsforyou #nextgenerationeu #eufunds
Read more
17,2 mln PLN
Project value
14,9 mln PLN
EU funding
> 6 mln PLN
Purchase of equipment
2024–2026
Implementation period
About the project
Innovative diagnostic and prognostic panel for early diagnosis of chronic lymphocytic leukemia
The aim of the project is to develop a practical diagnostic and prognostic panel based on quantitative assessment of nucleic acid modifications in cells and biological material from CLL patients. The procedures developed are intended to increase the sensitivity and specificity of diagnostics, facilitate early differential diagnosis (e.g., CLL vs. MBL/SLL), improve prognosis assessment, and enable more effective monitoring of response to therapy, including minimal residual disease (MRD).
Learn about the projectResearch areas
Three pillars of an innovative diagnostic and prognostic panel
Molecular diagnostics of CLL
Identification and validation of molecular biomarkers of chronic lymphocytic leukemia using NGS sequencing and flow cytometry methods.
AI predictive models
Development of machine learning algorithms integrating clinical, genomic, and proteomic data for predicting the course of CLL.
Diagnostic panel
Development of an innovative diagnostic and prognostic panel ready for implementation in clinical hematology practice.
News
Latest information on project implementation
Testing DNA extraction efficiency using commercially available kits
#benefitstoyou #nextgenerationeu #eufunds #dna #cmumk #laboratory #science #innovation
Read more
Optimization of the “dry drop” method
#benefitstoyou #nextgenerationeu #eufunds #laboratory #cmumk #hematology #immunology #modern diagnostics #science #driedbloodspot #drydropmethod
Read moreInterested in working with us?
Please contact us — we will respond as soon as possible.